Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Aneurysmal Subarachnoid Haemorrhage (Phase III)
2016-003725-42Phase 3Unknown
- Sponsor
- The University of Manchester
- Start
- Jun 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Anakinra arm with Placebo arm (2 arms). Primary endpoint: Ordinal shift in modified Rankin Scale at 6 months. Status: unknown.
02
Drugs
anakinra
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2016-003725-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003725-42.